BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1880913)

  • 1. [Treatment of severe infections in hematologic malignancies with piperacillin sodium].
    Kubota Y; Ohnishi H; Murata M; Nagai M; Ikeda K; Tanaka T; Irino S
    Jpn J Antibiot; 1991 Mar; 44(3):317-23. PubMed ID: 1880913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
    Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of cefozopran for infections associated with hematological malignancies].
    Sasai Y; Iwai T; Tamura A; Nakazawa N; Ueda Y; Kaneko H; Horiike S; Yokota S; Taniwaki M; Kashima K; Misawa S; Tsuda S; Ohgawara Y
    Jpn J Antibiot; 1998 Aug; 51(8):501-8. PubMed ID: 9836122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of aztreonam for infections accompanying febrile neutropenic children with hematologic disorders and solid tumors. A cooperative study].
    Hirotsu T; Akatsuka J; Hoshi Y; Uchiyama H; Fujisawa K; Kobayashi N; Ishidoya N; Ohira M; Takayama J; Ishida Y
    Jpn J Antibiot; 1990 Dec; 43(12):2069-77. PubMed ID: 2086821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
    Toyama K; Torii Y; Aoki I; Kikuchi M; Wakasugi K
    Jpn J Antibiot; 1992 Aug; 45(8):1003-8. PubMed ID: 1433888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
    Yildirim I; Aytac S; Ceyhan M; Cetin M; Tuncer M; Cengiz AB; Secmeer G; Yetgin S
    Pediatr Hematol Oncol; 2008 Jun; 25(4):291-9. PubMed ID: 18484473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperacillin and netilmicin combination therapy for febrile episodes in neutropenic patients.
    Herbrecht R; Damonte JC; Bergerat JP; Jehl F; Liu KL; Prevost G; Dufour P; Duclos B; Oberling F
    Infection; 1990; 18(5):310-3. PubMed ID: 2276828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fever in children with hematologic neoplastic diseases and implanted Broviac-Hickman catheters].
    Pilecki O; Wysocki M; Swiatkiewicz V; Kołtan A; Kołtan S; Kurylak A; Kurylak D
    Pediatr Pol; 1995 Mar; 70(3):213-8. PubMed ID: 8657488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies.
    Bow EJ; Rotstein C; Noskin GA; Laverdiere M; Schwarer AP; Segal BH; Seymour JF; Szer J; Sanche S
    Clin Infect Dis; 2006 Aug; 43(4):447-59. PubMed ID: 16838234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, open-label noncomparative study with piperacillin-tazobactam monotherapy as management of fever in patients with acute leukemia.
    Fanci R; Bartolozzi B; Longo G; Bosi A
    J Chemother; 2008 Aug; 20(4):492-6. PubMed ID: 18676231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cefmetazole and piperacillin with or without tobramycin for infections in patients with hematological disorders.
    Nagao T; Komatsuda M; Yamauchi K; Nozaki H; Arimori S
    Tokai J Exp Clin Med; 1981 Oct; 6(4):415-20. PubMed ID: 6459664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
    Tsai MS; Kuo CY; Wang MC; Wu HC; Chien CC; Liu JW
    J Microbiol Immunol Infect; 2006 Apr; 39(2):150-4. PubMed ID: 16604248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of sulbactam/cefoperazone for infections during the chemotherapy of hematologic malignancy].
    Kawai Y; Ueda T; Iwasaki H; Nakamura T
    Jpn J Antibiot; 1994 Sep; 47(9):1196-201. PubMed ID: 7990260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.
    Siami G; Christou N; Eiseman I; Tack KJ;
    Antimicrob Agents Chemother; 2001 Feb; 45(2):525-31. PubMed ID: 11158750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders].
    Mizuno H; Yamao H; Saito H; Ohno R; Hotta T; Ohnishi K; Murate T; Kagami Y; Mitomo Y; Nitta M
    Jpn J Antibiot; 1990 Dec; 43(12):2078-86. PubMed ID: 2086822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic effectiveness of aztreonam on severe infections associated with hematologic disorders. Hanshin Infection Study Group].
    Hirayama F; Masaoka T; Shibata H; Nagai K; Kitani T; Horiuchi A; Kawagoe H; Yasunaga K; Okamoto Y; Yonezawa T
    Jpn J Antibiot; 1985 Sep; 38(9):2402-12. PubMed ID: 4079014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of imipenem/cilastatin sodium and fosfomycin as second-line combination chemotherapy in severe infections associated with hematologic disorders].
    Tsuda S; Kuzuyama Y; Nakai H; Seriu T; Takashima T; Tanaka S; Horiike S; Taniwaki M; Misawa S; Kashima K
    Jpn J Antibiot; 1993 Feb; 46(2):171-83. PubMed ID: 8331778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of a combination therapy using cefmenoxime and cefsulodin on infections complicated by hematological disorders. Tohkai Research Group on Infections in Hematopoietic Disorders].
    Minami N; Uno N; Shirakawa S; Ohno R; Okumura M; Yamamoto M; Mitomo Y; Hirano M; Shimizu S; Yamada K
    Jpn J Antibiot; 1986 Mar; 39(3):713-20. PubMed ID: 3488423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders.
    Sato T; Kobayashi R; Yasuda K; Kaneda M; Iguchi A; Kobayashi K
    Pediatr Blood Cancer; 2008 Dec; 51(6):774-7. PubMed ID: 18661495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.